A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

This study has been terminated.
Sponsor:
Information provided by:
Titan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00083473
First received: May 24, 2004
Last updated: August 26, 2005
Last verified: August 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2005
  Estimated Primary Completion Date: No date given